Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune marker expression and prognosis of early breast cancer expressing HER3. | Eur J Cancer | 2024 | 39447449 | PubTator, text mining | PubMed |
| A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis. | Curr Ther Res Clin Exp | 2024 | 39434898 | PubTator, text mining | PubMed |
| Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo. | Anal Chem | 2024 | 39392424 | PubTator, text mining | PubMed |
| Expression of B7-H3 and B7-H4 in Gastric Gastrointestinal Stromal Tumors. | Appl Immunohistochem Mol Morphol | 2024 | 39365659 | PubTator, text mining | PubMed |
| Marmoset and human trophoblast stem cells differ in signaling requirements and recapitulate divergent modes of trophoblast invasion. | Cell Stem Cell | 2024 | 39321797 | PubTator, text mining | PubMed |
| Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer. | Heliyon | 2024 | 39286099 | PubTator, text mining | PubMed |
| The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives. | Front Immunol | 2024 | 39267740 | PubTator, text mining | PubMed |
| A graph self-supervised residual learning framework for domain identification and data integration of spatial transcriptomics. | Commun Biol | 2024 | 39266614 | PubTator, text mining | PubMed |
| Are cities under bright lights more innovative? Evidence from China. | Heliyon | 2024 | 39253158 | PubTator, text mining | PubMed |
| Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins. | Lab Invest | 2024 | 39244158 | PubTator, text mining | PubMed |
| Tuning Immune-Cold Tumor by Suppressing USP10/B7-H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs. | Adv Sci (Weinh) | 2024 | 39206932 | PubTator, text mining | PubMed |
| Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints. | Cancers (Basel) | 2024 | 39199578 | PubTator, text mining | PubMed |
| Impact of the Immunomodulatory Factor Soluble B7-H4 in the Progress of Preeclampsia by Inhibiting Essential Functions of Extravillous Trophoblast Cells. | Cells | 2024 | 39195262 | PubTator, text mining | PubMed |
| An integrated bioinformatic investigation of kallikrein gene family members in kidney renel cell carcinoma. | PLoS One | 2024 | 39116105 | PubTator, text mining | PubMed |
| Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting. | Crit Rev Oncol Hematol | 2024 | 39111458 | PubTator, text mining | PubMed |
| The clinical landscape of antibody-drug conjugates in endometrial cancer. | Int J Gynecol Cancer | 2024 | 39074933 | PubTator, text mining | PubMed |
| B7H4 Role in Solid Cancers: A Review of the Literature. | Cancers (Basel) | 2024 | 39061159 | PubTator, text mining | PubMed |
| Differential Immune Checkpoint Protein Expression in HNSCC: The Role of HGF/MET Signaling. | Int J Mol Sci | 2024 | 39000441 | PubTator, text mining | PubMed |
| Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. | Cell | 2024 | 38968937 | PubTator, text mining | PubMed |
| Dehydroepiandrosterone attenuated the immune escape of oral squamous cell carcinoma through NF-κB p65/miR-15b-5p/B7-H4 axis. | Int Immunopharmacol | 2024 | 38885603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=8